175 related articles for article (PubMed ID: 35711002)
21. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women.
Hirao M; Hashimoto J; Ando W; Ono T; Yoshikawa H
J Bone Miner Metab; 2008; 26(3):260-4. PubMed ID: 18470667
[TBL] [Abstract][Full Text] [Related]
22. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y
J Bone Miner Metab; 2014 Mar; 32(2):142-50. PubMed ID: 23702931
[TBL] [Abstract][Full Text] [Related]
23. Effect of Vitamin K2 Alone or in Combination on Various Bone Turnover Markers Amongst Postmenopausal Females.
AlHajri L; Ayoub A; Ahmed H; AlMulla M
J Bone Metab; 2021 Feb; 28(1):11-26. PubMed ID: 33730780
[TBL] [Abstract][Full Text] [Related]
24. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol.
Inoue T; Sugiyama T; Matsubara T; Kawai S; Furukawa S
Endocr J; 2001 Feb; 48(1):11-8. PubMed ID: 11403096
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
26. Maximal dose-response of vitamin-K2 (menaquinone-4) on undercarboxylated osteocalcin in women with osteoporosis.
K Giri T; Newton D; Chaudhary O; Deych E; Napoli N; Villareal R; Diemer K; E Milligan P; F Gage B
Int J Vitam Nutr Res; 2020 Jan; 90(1-2):42-48. PubMed ID: 30816822
[No Abstract] [Full Text] [Related]
27. The combined effect of vitamin K and calcium on bone mineral density in humans: a meta-analysis of randomized controlled trials.
Hu L; Ji J; Li D; Meng J; Yu B
J Orthop Surg Res; 2021 Oct; 16(1):592. PubMed ID: 34649591
[TBL] [Abstract][Full Text] [Related]
28. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.
Binkley N; Harke J; Krueger D; Engelke J; Vallarta-Ast N; Gemar D; Checovich M; Chappell R; Suttie J
J Bone Miner Res; 2009 Jun; 24(6):983-91. PubMed ID: 19113922
[TBL] [Abstract][Full Text] [Related]
29. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy.
Iwamoto I; Kosha S; Noguchi S; Murakami M; Fujino T; Douchi T; Nagata Y
Maturitas; 1999 Jan; 31(2):161-4. PubMed ID: 10227010
[TBL] [Abstract][Full Text] [Related]
30. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.
Shiraki M; Shiraki Y; Aoki C; Miura M
J Bone Miner Res; 2000 Mar; 15(3):515-21. PubMed ID: 10750566
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women.
Atalay S; Elci A; Kayadibi H; Onder CB; Aka N
Ann Lab Med; 2012 Jan; 32(1):23-30. PubMed ID: 22259775
[TBL] [Abstract][Full Text] [Related]
32. Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women.
Koitaya N; Ezaki J; Nishimuta M; Yamauchi J; Hashizume E; Morishita K; Miyachi M; Sasaki S; Ishimi Y
J Nutr Sci Vitaminol (Tokyo); 2009 Feb; 55(1):15-21. PubMed ID: 19352059
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of walking for preservation of bone mineral density in postmenopausal women.
Martyn-St James M; Carroll S
Bone; 2008 Sep; 43(3):521-31. PubMed ID: 18602880
[TBL] [Abstract][Full Text] [Related]
34. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD005326. PubMed ID: 17054253
[TBL] [Abstract][Full Text] [Related]
35. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Ichimura S
Keio J Med; 2003 Sep; 52(3):147-50. PubMed ID: 14529146
[TBL] [Abstract][Full Text] [Related]
36. Time-dependent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women.
Ozuru R; Sugimoto T; Yamaguchi T; Chihara K
Endocr J; 2002 Jun; 49(3):363-70. PubMed ID: 12201222
[TBL] [Abstract][Full Text] [Related]
37. Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials.
Wang YK; Qin SQ; Ma T; Song W; Jiang RQ; Guo JB; Li K; Zhang YM
Medicine (Baltimore); 2017 May; 96(21):e6970. PubMed ID: 28538396
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of elcatonin in postmenopausal women with osteoporosis: a systematic review with network meta-analysis of randomized clinical trials.
Chen WC; Lin EY; Kang YN
Osteoporos Int; 2019 Sep; 30(9):1723-1732. PubMed ID: 31041475
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of vitamin K2 on osteoporosis in adults with cerebral palsy.
Kodama Y; Okamoto Y; Kubota T; Hiroyama Y; Fukami H; Matsushita K; Kawano Y
Brain Dev; 2017 Nov; 39(10):846-850. PubMed ID: 28624135
[TBL] [Abstract][Full Text] [Related]
40. Effects of isoflavone interventions on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Sansai K; Na Takuathung M; Khatsri R; Teekachunhatean S; Hanprasertpong N; Koonrungsesomboon N
Osteoporos Int; 2020 Oct; 31(10):1853-1864. PubMed ID: 32524173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
